SCHEMBL25944837

SCHEMBL25944837

CC(C)Cc1cccc2cc(Cn3cccc(NC=O)c3=O)n(C(=O)OC(C)(C)C)c12

nearest known ligand 0.63

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
MAP4K1 Q92918 20/20 0.63

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21684615 0.86 MAP4K1 (0.58) MAP4K1
SCHEMBL31303996 0.86 MAP4K1 (0.58) MAP4K1
SCHEMBL25944736 0.84 MAP4K1 (0.62) MAP4K1
SCHEMBL25945205 0.83 MAP4K1 (0.63) MAP4K1
SCHEMBL25938521 0.81 MAP4K1 (0.49) MAP4K1
SCHEMBL25944771 0.81 MAP4K1 (0.76) MAP4K1
SCHEMBL25945848 0.79 MAP4K1 (0.62) MAP4K1
SCHEMBL21702975 0.79 MAP4K1 (0.76) MAP4K1
SCHEMBL21703355 0.78 MAP4K1 (0.86) MAP4K1
SCHEMBL30203200 0.78 MAP4K1 (0.86) MAP4K1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4219460-A1 TRANSGLUTAMINASE 2 (TG2) INHIBITORS Sitari Pharma, Inc. (US) 2023-08-02 EP disclosed